We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TxCell Raises EUR 12.4 Million (USD 16 million) in a Third Financing Round

News   Nov 27, 2012

 
TxCell Raises EUR 12.4 Million (USD 16 million) in a Third Financing Round
 
 
 

RELATED ARTICLES

HIV Therapy Reduces Virus and Boosts Immunity in Drug-Resistant Patients

News

A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options.

READ MORE

Breast Cancers Enlist the Help of Normal Cells to Help Them Spread & Survive

News

Researchers have shown that triple negative breast tumours - which are the most aggressive and have the fewest treatment options - might one day be treated with a drug that cuts the 'phone lines' between normal cells and tumour cells.

READ MORE

Tdap Vaccination for Pregnant Women Does Not Increase Risk of Autism, Finds Study

News

A Kaiser Permanente study of more than 80,000 children born over a 4-year period showed that the prenatal Tdap vaccination (tetanus, diphtheria, acellular pertussis) was not associated with increased risk of autism spectrum disorder in children.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE